3ONITILO A A,ENGEL J M,LUNDGREN C I,et al.Simplifying the TNM system for clinical use in differentiated thyroid cancer[J].J Clin Oncol,2009,27(11):1872-1878. 被引量：1
4MAZZAFERRI E L,JHIANG S M.Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer[J].Am J Med,1994,97(5):418-428. 被引量：1
5COOPER D S,DOHERTY G M,HAUGEN B R,et al.Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer[J].Thyroid,2009,19(11):1167-1214. 被引量：1
6SCHLUMBERGER M,BERG G,COHEN O,et al.Follow-up of low-risk patients with differentiated thyroid carcinoma:a European perspective[J].Eur J Endocrinol,2004,150(2):105-112. 被引量：1
7Z(O)PHEL K,WUNDERLICH G,KOTZERKE J.A highly sensitive thyroglobulin assay has superior diagnostic sensitivity for recurrence of differentiated thyroid cancer in patients undergoing TSH suppression[J].J Nucl Med,2006,47(3):552-553. 被引量：1
8SPENCER C A.Challenges of serum thyroglobulin (Tg) measurement in the presence of Tg autoantibodies[J].J Clin Endocrinol Metab,2004,89(8):3702-3704. 被引量：1
